H40.60 Glaucoma secondary to drugs, unspecified eye

Name of the Condition

• Glaucoma Secondary to Drugs, Unspecified Eye

Summary

Glaucoma secondary to drugs, unspecified eye, is a condition where increased intraocular pressure (IOP) or optic nerve damage occurs due to the use of certain medications. This form of glaucoma may develop when drugs disrupt the eye’s fluid drainage system or directly affect optic nerve health, potentially leading to vision loss if not identified and managed promptly.

Causes

The condition arises when medications alter the eye’s normal fluid outflow or damage the optic nerve. Common mechanisms include drugs that impair the trabecular meshwork, reduce aqueous humor drainage, or have direct toxic effects on the optic nerve. Examples include corticosteroids, certain antidepressants, and anticholinergic agents, which can elevate IOP or cause optic nerve changes over time.

Risk Factors

• Prolonged use of corticosteroid medications (topical, inhaled, or systemic).
• Use of drugs known to affect intraocular pressure (e.g., some anticholinergics, antipsychotics).
• Pre-existing ocular conditions that increase susceptibility to drug-induced pressure changes.
• Genetic predisposition to steroid responsiveness.

Symptoms

• Elevated intraocular pressure (detected via tonometry).
• Vision changes, such as blurred vision or halos around lights.
• Eye discomfort or pain (less common).
• Progressive vision loss, particularly in peripheral fields.

Diagnosis

Diagnosis involves a comprehensive eye examination, including tonometry to measure intraocular pressure, visual field testing to detect peripheral vision loss, and imaging (e.g., optical coherence tomography) to assess optic nerve damage. A detailed medication history is critical for correlation.

Treatment Options

Treatment focuses on discontinuing or adjusting the causative drug, if possible, and managing IOP. Options may include topical or oral medications to lower pressure, laser therapy, or surgery to improve fluid drainage. Regular monitoring is essential to prevent further optic nerve damage.

Prognosis and Follow-Up

Prognosis depends on early detection and management. With appropriate intervention, vision loss can often be slowed or prevented. Follow-up typically includes regular IOP checks, visual field testing, and optic nerve imaging to monitor for progression.

Complications

• Permanent vision loss or blindness if untreated.
• Optic nerve damage leading to irreversible visual field defects.
• Increased risk of other ocular complications, such as cataracts.

Lifestyle & Prevention

• Avoid or limit use of medications known to elevate IOP, when possible.
• Regular eye examinations, especially for those on long-term drug therapy.
• Prompt reporting of vision changes or eye discomfort to a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, or persistent blurred vision, as these may indicate acute pressure elevation or optic nerve damage.

Tips for Medical Coders

Document the specific drug or class of drugs causing the glaucoma, if known, to support coding accuracy. For unspecified eye, ensure the record confirms the condition affects one or both eyes without further specification. Include details on medication history, IOP measurements, and any related ocular findings to justify the diagnosis.